Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Newborn Eye Imaging Systems Market 

5.1. COVID-19 Landscape: Newborn Eye Imaging Systems Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Newborn Eye Imaging Systems Market, By Disease Type

8.1. Newborn Eye Imaging Systems Market, by Disease Type, 2023-2032

8.1.1 ROP

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Retinal Disease

8.1.2.1. Market Revenue and Forecast (2020-2032)

8.1.3. Strabismus

8.1.3.1. Market Revenue and Forecast (2020-2032)

8.1.4. Refractive Error

8.1.4.1. Market Revenue and Forecast (2020-2032)

8.1.5. Color Blindness

8.1.5.1. Market Revenue and Forecast (2020-2032)

8.1.6. Others

8.1.6.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Newborn Eye Imaging Systems Market, By Device Type

9.1. Newborn Eye Imaging Systems Market, by Device Type, 2023-2032

9.1.1. Basic Device

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Wireless Device

9.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Newborn Eye Imaging Systems Market, By End-User 

10.1. Newborn Eye Imaging Systems Market, by End-User, 2023-2032

10.1.1. Hospitals

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Ophthalmology Diagnosis Centers

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. Ambulatory Surgical Centers

10.1.3.1. Market Revenue and Forecast (2020-2032)

10.1.4. Others

10.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Newborn Eye Imaging Systems Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Disease Type (2020-2032)

11.1.2. Market Revenue and Forecast, by Device Type (2020-2032)

11.1.3. Market Revenue and Forecast, by End-User (2020-2032)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Disease Type (2020-2032)

11.1.4.2. Market Revenue and Forecast, by Device Type (2020-2032)

11.1.4.3. Market Revenue and Forecast, by End-User (2020-2032)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Disease Type (2020-2032)

11.1.5.2. Market Revenue and Forecast, by Device Type (2020-2032)

11.1.5.3. Market Revenue and Forecast, by End-User (2020-2032)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Disease Type (2020-2032)

11.2.2. Market Revenue and Forecast, by Device Type (2020-2032)

11.2.3. Market Revenue and Forecast, by End-User (2020-2032)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Disease Type (2020-2032)

11.2.4.2. Market Revenue and Forecast, by Device Type (2020-2032)

11.2.4.3. Market Revenue and Forecast, by End-User (2020-2032)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Disease Type (2020-2032)

11.2.5.2. Market Revenue and Forecast, by Device Type (2020-2032)

11.2.5.3. Market Revenue and Forecast, by End-User (2020-2032)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Disease Type (2020-2032)

11.2.6.2. Market Revenue and Forecast, by Device Type (2020-2032)

11.2.6.3. Market Revenue and Forecast, by End-User (2020-2032)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Disease Type (2020-2032)

11.2.7.2. Market Revenue and Forecast, by Device Type (2020-2032)

11.2.7.3. Market Revenue and Forecast, by End-User (2020-2032)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Disease Type (2020-2032)

11.3.2. Market Revenue and Forecast, by Device Type (2020-2032)

11.3.3. Market Revenue and Forecast, by End-User (2020-2032)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Disease Type (2020-2032)

11.3.4.2. Market Revenue and Forecast, by Device Type (2020-2032)

11.3.4.3. Market Revenue and Forecast, by End-User (2020-2032)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Disease Type (2020-2032)

11.3.5.2. Market Revenue and Forecast, by Device Type (2020-2032)

11.3.5.3. Market Revenue and Forecast, by End-User (2020-2032)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Disease Type (2020-2032)

11.3.6.2. Market Revenue and Forecast, by Device Type (2020-2032)

11.3.6.3. Market Revenue and Forecast, by End-User (2020-2032)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Disease Type (2020-2032)

11.3.7.2. Market Revenue and Forecast, by Device Type (2020-2032)

11.3.7.3. Market Revenue and Forecast, by End-User (2020-2032)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Disease Type (2020-2032)

11.4.2. Market Revenue and Forecast, by Device Type (2020-2032)

11.4.3. Market Revenue and Forecast, by End-User (2020-2032)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Disease Type (2020-2032)

11.4.4.2. Market Revenue and Forecast, by Device Type (2020-2032)

11.4.4.3. Market Revenue and Forecast, by End-User (2020-2032)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Disease Type (2020-2032)

11.4.5.2. Market Revenue and Forecast, by Device Type (2020-2032)

11.4.5.3. Market Revenue and Forecast, by End-User (2020-2032)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Disease Type (2020-2032)

11.4.6.2. Market Revenue and Forecast, by Device Type (2020-2032)

11.4.6.3. Market Revenue and Forecast, by End-User (2020-2032)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Disease Type (2020-2032)

11.4.7.2. Market Revenue and Forecast, by Device Type (2020-2032)

11.4.7.3. Market Revenue and Forecast, by End-User (2020-2032)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Disease Type (2020-2032)

11.5.2. Market Revenue and Forecast, by Device Type (2020-2032)

11.5.3. Market Revenue and Forecast, by End-User (2020-2032)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Disease Type (2020-2032)

11.5.4.2. Market Revenue and Forecast, by Device Type (2020-2032)

11.5.4.3. Market Revenue and Forecast, by End-User (2020-2032)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Disease Type (2020-2032)

11.5.5.2. Market Revenue and Forecast, by Device Type (2020-2032)

11.5.5.3. Market Revenue and Forecast, by End-User (2020-2032)

Chapter 12. Company Profiles

12.1. Visunex Medical Systems

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Eye Photo Systems

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. MergeHealthcare

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. D-EYE

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Imagine Eyes

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Natus Medical

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Servicom Medical

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms